Filing Flows

Filing Flows › Financials › Health In Tech (HIT)

Health In Tech (HIT) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Health In Tech (HIT) Q2 2026 earnings results →

Q2 2026 Revenue down 14% year over year to $8.1M · 31¢ of every $1 of revenue lost · operating margin -41.2%

Health In Tech made $8.1M in Q2 2026 (-14% Y/Y). Operating margin -41.2%, net loss $2.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.

Revenue$8.1M
Year over year-14%
Operating margin-41.2%
Net earnings−$2.5M
Operating cash flow−$2.9M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $8.1M in Q2 2026, down 13% year over year and down 8% from the previous quarter. Self Funded Plan Administration Fees was the largest line at 63% of revenue. Program and Platform Management Fees lost $5.0M year over year (down 74%), 400% of the total change.

Gross margin was 48.7%, down 19.1 points from Q2 2025. Operating costs exceeded revenue by $3.3M, an operating margin of -41.2%. Operating expenses grew 32% against a revenue fall of 13%. The quarter ended with a net loss of $2.5M, wider than the previous quarter's $1.6M loss.

Operating cash flow was −$2.9M. Non-cash charges added back $320K of depreciation and amortization and $1.0M of share-based compensation. Working capital and other items used $1.7M.

Quarterly history

Health In Tech revenue by quarterHealth In Tech revenue by quarter$4.9MQ4 2024$8.0MQ1 2025$9.3MQ2 2025$8.5MQ3 2025$7.5MQ4 2025$8.8MQ1 2026$8.1MQ2 2026
Health In Tech net earnings by quarterHealth In Tech net earnings by quarter−$144KQ4 2024$499KQ1 2025$631KQ2 2025$452KQ3 2025−$303KQ4 2025−$1.6MQ1 2026−$2.5MQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 13, 2026$8.1M-14%-41.2%−$2.5M−$2.9M
Q1 202610-QMay 14, 2026$8.8M+9%-23.6%−$1.6M−$3.3M
Q4 202510-KMar 25, 2026$7.5M+53%-5.9%−$303K$451K
Q3 202510-QNov 12, 2025$8.5M+90%7.1%$452K$674K
Q2 202510-QAug 8, 2025$9.3M+86%8.9%$631K$1.5M
Q1 202510-QMay 9, 2025$8.0M+56%8.5%$499K$527K
Q4 202410-KMar 17, 2025$4.9M—-2.3%−$144K−$531K

Charts

Health In Tech: revenue growth, year over year and quarter over quarterHealth In Tech: revenue growth, year over year and quarter over quarterY/YQ/Q+56%+63%Q1 2025+86%+16%Q2 2025+90%-9%Q3 2025+53%-12%Q4 2025+9%+17%Q1 2026-14%-8%Q2 2026
Latest (Q2 2026): Y/Y -14%, Q/Q -8%.
Health In Tech: where the cash came from (+) and went (−), TTM to Q2 2026Health In Tech: where the cash came from (+) and went (−), TTM to Q2 2026Other financing$6.0MOperating cash flow−$5.1MOther investing−$2.5MCash drawn (+) / kept (−)$1.6M
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Health In Tech: profit against cash, quarter by quarterHealth In Tech: profit against cash, quarter by quarterNet incomeOperating cash flow$376K$2.1MQ3 2024−$144K−$531KQ4 2024$499K$527KQ1 2025$631K$1.5MQ2 2025$452K$674KQ3 2025−$303K$451KQ4 2025−$1.6M−$3.3MQ1 2026−$2.5M−$2.9MQ2 2026
Latest (Q2 2026): Net income −$2.5M, Operating cash flow −$2.9M.
Health In Tech in its industry: growth against margin (24 companies, SIC 6411)Health In Tech in its industry: growth against margin (24 companies, SIC 6411)revenue growth, year over year →↑ operating marginmedian +8%median 17%MRSHAONAJGEQHWTWBROERIERYANBWINARXHGTYCRD-AACTSLQTCRVLLIFEGSHDTWFGNPEHTHRDZNQDMIEZRAHIT (-14%, -41%)
Insurance Agents, Brokers & Service; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Customers and suppliers named in filings

Buys from

About Health In Tech

To change the non-transparent $5.3 trillion 1 healthcare industry with innovation that removes friction and complexities with vertical integration, process simplification, automation, and digitalization. Health in Tech (“HIT”) is an AI-enabled insurance technology platform company, which offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators (“TPAs”).

In its own words, from its 10-K, filed Mar 25, 2026.

Health In Tech against its Insurance Agents, Brokers & Service peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -14% against the peers' median +7%. Operating margin: -41.2% against the peers' median 17.8%.

CompanyQuarterRevenueY/YOp. margin
HIT Health In TechQ2 2026$8.1M-14%-41.2%
MRSH Marsh & McLennan CompaniesQ3 2026$6.9B+8%17.7%
AON AonQ3 2026$4.1B+3%19.7%
AJG Arthur J. GallagherQ3 2026$4.0B+18%13.0%
EQH Equitable HoldingsQ3 2026$3.9B+168%35.8%
WTW Willis Towers WatsonQ3 2026$2.5B+8%17.4%
BRO Brown & BrownQ3 FY27$1.7B+7%18.6%
ERIE Erie IndemnityQ3 2026$1.1B+0.3%19.4%
RYAN Ryan Specialty HoldingsQ3 2026$790M+5%17.8%

Source: Health In Tech 10-Q on SEC EDGAR · CIK 2019505 · Insurance Agents, Brokers & Service

13F: who owns HIT and who is buying

Largest holders of HIT (13F)Largest holders of HIT (13F)Whetstone Capital Advisors, LLC$1.5MMink Brook Asset Management LLC$1.1MVanguard Group$1.0MVanguard Capital Management LLC$574KHeights Capital Management$354KBlackRock$353KGeode Capital Management, LLC$223KCitadel Advisors LLC$179KVanguard Fiduciary Trust$132KState Street$64K
Funds' net buying of HIT by quarter (13F)Funds' net buying of HIT by quarter (13F)$02024-12$488K2025-03−$329K2025-06$2.6M2025-09−$429K2025-12$694K2026-03$2.1M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on HIT

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

Compare HIT with

中文版:Health In Tech(HIT)财报

Español · Français